Your browser doesn't support javascript.
loading
Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial.
Sharma, Mukul; Hart, Robert G; Smith, Eric E; Bosch, Jackie; Yuan, Fei; Casanova, Amparo; Eikelboom, John W; Connolly, Stuart J; Wong, Gloria; Diaz, Rafael; Lopez-Jaramillo, Patricio; Ertl, Georg; Störk, Stefan; Dagenais, Gilles R; Lonn, Eva M; Ryden, Lars; Tonkin, Andrew M; Varigos, John D; Bhatt, Deepak L; Branch, Kelley Rh; Probstfield, Jeffrey L; Kim, Jae-Hyung; Ha, Jong-Won; O'Donnell, Martin; Vinereanu, Dragos; Fox, Keith Aa; Liang, Yan; Liu, Lisheng; Zhu, Jun; Pogosova, Nana; Maggioni, Aldo P; Avezum, Alvaro; Piegas, Leopoldo S; Keltai, Katalin; Keltai, Matyas; Cook Bruns, Nancy; Berkowitz, Scott; Yusuf, Salim.
Afiliación
  • Sharma M; 1 Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Hart RG; 1 Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Smith EE; 2 Hotchkiss Brain Institute, University of Calgary, Calgary Canada.
  • Bosch J; 1 Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Yuan F; 3 School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada.
  • Casanova A; 1 Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Eikelboom JW; 1 Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Connolly SJ; 1 Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Wong G; 1 Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Diaz R; 1 Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Lopez-Jaramillo P; 3 School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada.
  • Ertl G; 4 Estudios Clínicos Latino America and Instituto Cardiovascular de Rosario, Rosario, Argentina.
  • Störk S; 5 Research Institute, FOSCAL-Bucaramanga, Bucaramanga, Colombia.
  • Dagenais GR; 6 Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.
  • Lonn EM; 6 Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.
  • Ryden L; 7 Institut Universitaire de Cardiologie et Pneumologie de Quebec, Quebec City, Quebec, Canada.
  • Tonkin AM; 1 Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Varigos JD; 8 Karolinska Institutet, Stockholm, Sweden.
  • Bhatt DL; 9 Monash University, Melbourne, Australia.
  • Branch KR; 9 Monash University, Melbourne, Australia.
  • Probstfield JL; 10 Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Kim JH; 11 University of Washington Medical Centre, Seattle, WA, USA.
  • Ha JW; 12 University of Washington, Seattle, WA, USA.
  • O'Donnell M; 13 The Catholic University of Korea, Seoul, Korea.
  • Vinereanu D; 14 Yonsei University College of Medicine, Seoul, Korea.
  • Fox KA; 15 National University of Ireland, Galway, Ireland.
  • Liang Y; 16 University of Medicine and Pharmacology Carol Davila University and Emergency Hospital, Bucharest, Romania.
  • Liu L; 17 Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, Scotland.
  • Zhu J; 18 FuWai Hospital, Beijing, China.
  • Pogosova N; 18 FuWai Hospital, Beijing, China.
  • Maggioni AP; 18 FuWai Hospital, Beijing, China.
  • Avezum A; 19 National Research Centre for Preventative Medicine (Moscow), Moscow, Russia.
  • Piegas LS; 20 ANMCO Research Center, Florence, Italy.
  • Keltai K; 21 Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil.
  • Keltai M; 22 University of Sao Paulo, Sao Paulo, Brazil.
  • Cook Bruns N; 23 Semmelweis University, Budapest, Hungary.
  • Berkowitz S; 23 Semmelweis University, Budapest, Hungary.
  • Yusuf S; 24 Bayer AG, Leverkusen, Germany.
Int J Stroke ; 14(3): 270-281, 2019 04.
Article en En | MEDLINE | ID: mdl-30058959
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Encéfalo / Isquemia Encefálica / Trastornos del Conocimiento / Accidente Cerebrovascular / Infarto Encefálico / Rivaroxabán / Anticoagulantes Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Revista: Int J Stroke Año: 2019 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Encéfalo / Isquemia Encefálica / Trastornos del Conocimiento / Accidente Cerebrovascular / Infarto Encefálico / Rivaroxabán / Anticoagulantes Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Revista: Int J Stroke Año: 2019 Tipo del documento: Article País de afiliación: Canadá